Biopharma index seen spurring innovation

SHANGHAI: A new stock market index focused on biopharmaceutical equities will launch on May 9 and is expected to facilitate innovation in the industry, besides spurring high-quality development in the country, experts said.

The Shanghai Stock Exchange (SSE) and China Securities Index Co Ltd jointly announced on Tuesday that the Star Market Biology and Medicine Index will include 50 large-cap biopharmaceutical companies listed on the Star Market, which is part of the Shanghai bourse.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!


Next In Business News

Uphill battle to make money from rewilding
Investment house slumps after reallocating to private markets
Hyundai, Kia recall 3 million cars in US over fire risk
Toyota global production rises in August
Expansion, new products to support Ancom growth
Renewables developer Red Rocket raises US$160mil
Glencore, Seriti weigh job cuts in South Africa
Singapore announces another plan on cost of living
Iconic signs franchise deal with Marriott
Meta putting AI in digital assistants, smart glasses

Others Also Read